Haemonetics Corporation Completes Acquisition of Attune Medical [Yahoo! Finance]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Yahoo! Finance
medical solutions to drive better patient outcomes, has completed its previously announced acquisition of privately-held Chicago -based Attune Medical, the manufacturer of the ensoETM ® proactive esophageal cooling device. EnsoETM is the only FDA-cleared temperature regulation device indicated for esophageal protection during radiofrequency (RF) cardiac ablation procedures. The acquisition includes an upfront cash payment of $160 million plus additional contingent consideration based on sales growth over the next three years and the achievement of certain other milestones. In fiscal year 2025, Haemonetics expects Attune Medical to contribute approximately to $35 million in revenue and to contribute approximately to to earnings per diluted share on a GAAP basis and approximately to to adjusted earnings per diluted share, excluding one-time acquisition and integration-related costs. Haemonetics financed this transaction through a combination of cash on hand and a $150 million draw und
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Haemonetics (HAE) Banks on Plasma Arm Growth Amid Rising Costs [Yahoo! Finance]Yahoo! Finance
- Apheresis Market is Expected to Reach $3.9 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Global $3.9 Bn Apheresis Market Forecast to 2029: Surge in Use for Leukaemia and Paediatric Patients Boosts Growth Prospects [Yahoo! Finance]Yahoo! Finance
- Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $105.00 price target on the stock.MarketBeat
- Why You Should Add Haemonetics (HAE) to Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
HAE
Earnings
- 2/8/24 - Beat
HAE
Sec Filings
- 5/1/24 - Form 8-K
- 4/17/24 - Form 4
- 4/1/24 - Form 8-K
- HAE's page on the SEC website